Related references
Note: Only part of the references are listed.High-sensitivity C-reactive protein and high mobility group box-1 levels in Parkinson's disease
Aslihan Baran et al.
NEUROLOGICAL SCIENCES (2019)
Cerebrospinal Fluid C-Reactive Protein in Parkinson's Disease: Associations with Motor and Non-motor Symptoms
Hossein Sanjari Moghaddam et al.
NEUROMOLECULAR MEDICINE (2018)
The Clinical Significance and Potential Role of C-Reactive Protein in Chronic Inflammatory and Neurodegenerative Diseases
Ying-yi Luan et al.
FRONTIERS IN IMMUNOLOGY (2018)
Cerebrospinal fluid concentrations of inflammatory markers in Parkinson's disease and atypical parkinsonian disorders
Sara Hall et al.
SCIENTIFIC REPORTS (2018)
Cerebrospinal fluid pro-inflammatory cytokines differentiate parkinsonian syndromes
C. Starhof et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Association of serum gamma-glutamyltransferase and C-reactive proteins with neuromyelitis optica and multiple sclerosis
Yaqing Shu et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)
The epidemiology of Parkinson's disease: risk factors and prevention
Alberto Ascherio et al.
LANCET NEUROLOGY (2016)
Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD)
Caroline H. Williams-Gray et al.
MOVEMENT DISORDERS (2016)
Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson's disease and its progression: Disease and staging biomarkers and new drug targets
Carine Coneglian de Farias et al.
NEUROSCIENCE LETTERS (2016)
Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease A Systematic Review and Meta-analysis
Xiao-Yan Qin et al.
JAMA NEUROLOGY (2016)
Neuroinflammation in the pathophysiology of Parkinson's disease and therapeutic evidence of anti-inflammatory drugs
Taysa Bervian Bassani et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2015)
Baseline Plasma C-Reactive Protein Concentrations and Motor Prognosis in Parkinson Disease
Atsushi Umemura et al.
PLOS ONE (2015)
Serum hs-CRP Levels are Increased in de Novo Parkinson's Disease Independently from Age of Onset
In-Uk Song et al.
EUROPEAN NEUROLOGY (2014)
Subclinical Elevation of Plasma C-Reactive Protein and Illusions/Hallucinations in Subjects with Parkinson's Disease: Case-control Study
Hideyuki Sawada et al.
PLOS ONE (2014)
Cerebrospinal fluid inflammatory markers in Parkinson's disease - Associations with depression, fatigue, and cognitive impairment
Daniel Lindqvist et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Is Neuroinflammation Involved in the Development of Dementia in Patients with Parkinson's Disease?
In-Uk Song et al.
INTERNAL MEDICINE (2013)
Triggering of Inflammasome by Aggregated α-Synuclein, an Inflammatory Response in Synucleinopathies
Gaia Codolo et al.
PLOS ONE (2013)
Plasma oxidative and inflammatory markers in patients with idiopathic Parkinson's disease
Gulnur Andican et al.
ACTA NEUROLOGICA BELGICA (2012)
C-reactive protein in intracerebral hemorrhage Time course, tissue localization, and prognosis
Mario Di Napoli et al.
NEUROLOGY (2012)
Non-Motor Symptoms in Patients with Parkinson's Disease - Correlations with Inflammatory Cytokines in Serum
Daniel Lindqvist et al.
PLOS ONE (2012)
C-reactive protein expression in a rodent model of chronic cerebral hypoperfusion
Wafa M. Juma et al.
BRAIN RESEARCH (2011)
Is C-reactive protein level a marker of advanced motor and neuropsychiatric complications in Parkinson's disease?
Sharon Hassin-Baer et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Non-Steroidal Anti-Inflammatory Drug Use and the Risk of Parkinson's Disease
Angelika D. Manthripragada et al.
NEUROEPIDEMIOLOGY (2011)
Association between high-sensitivity C-reactive protein and risk of early idiopathic Parkinson's disease
In-Uk Song et al.
NEUROLOGICAL SCIENCES (2011)
Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies
Karen Rees et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention
Malu G. Tansey et al.
NEUROBIOLOGY OF DISEASE (2010)
Is There an Association between the Level of High-Sensitivity C-Reactive Protein and Idiopathic Parkinson's Disease? A Comparison of Parkinson's Disease Patients, Disease Controls and Healthy Individuals
In-Uk Song et al.
EUROPEAN NEUROLOGY (2009)
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
K. Ray Chaudhuri et al.
LANCET NEUROLOGY (2009)
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C. Hirsch et al.
LANCET NEUROLOGY (2009)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
Alessandro Liberati et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Inflammation and neurodegeneration in Parkinson's disease
PL McGeer et al.
PARKINSONISM & RELATED DISORDERS (2004)
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease
HL Chen et al.
ARCHIVES OF NEUROLOGY (2003)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
The power of statistical tests in meta-analysis
LV Hedges et al.
PSYCHOLOGICAL METHODS (2001)
Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease
K Yasojima et al.
BRAIN RESEARCH (2000)
Share Paper
